Acorn Biolabs raised $11 million CAD in Series A funding led by Merz Aesthetics to expand its regenerative medicine services
Acorn Biolabs raised $11 million CAD in Series A funding led by Merz Aesthetics to expand its regenerative medicine services
06/03/24, 10:52 AM
Location
torontoMoney raised
$11 million
Industry
biotechnology
health care
Round Type
series a
Investors
Lee Li Holdings, The Leslie Group, Mde Investments, Telus Global Ventures, Merz Aesthetics
Acorn Biolabs, founded in 2017, has announced approximately $11 million CAD ($8 million USD) in Series A funding to enhance its stem cell preservation services for personalized regenerative medicine. The funding round was led by Merz Aesthetics with support from Telus Global Ventures, MDE Investments, The Leslie Group, Lee Li Holdings, and several undisclosed physicians in the aesthetics, orthopedic, and longevity fields. Acorn plans to use the capital to expand its commercial footprint and develop cosmetic offerings.
Company Info
Location
toronto, ontario, canada
Additional Info
Toronto-based biotechnology startup Acorn Biolabs aims to provide clients with access to personalized regenerative medicine through preserving cells for future hair regrowth, skin rejuvenation, injury recovery, and disease treatment.